Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CEFOTAXIME Cause Intracranial pressure increased? 10 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Intracranial pressure increased have been filed in association with CEFOTAXIME (Cefotaxime). This represents 0.3% of all adverse event reports for CEFOTAXIME.

10
Reports of Intracranial pressure increased with CEFOTAXIME
0.3%
of all CEFOTAXIME reports
10
Deaths
10
Hospitalizations

How Dangerous Is Intracranial pressure increased From CEFOTAXIME?

Of the 10 reports, 10 (100.0%) resulted in death, 10 (100.0%) required hospitalization, and 7 (70.0%) were considered life-threatening.

Is Intracranial pressure increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CEFOTAXIME. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does CEFOTAXIME Cause?

Drug reaction with eosinophilia and systemic symptoms (276) Drug ineffective (242) Pyrexia (211) Off label use (182) Acute kidney injury (170) Rash maculo-papular (151) Toxic epidermal necrolysis (151) Rash (125) Hepatocellular injury (122) Eosinophilia (121)

What Other Drugs Cause Intracranial pressure increased?

LEVONORGESTREL (195) SOMATROPIN (150) METHOTREXATE (140) PREDNISONE (127) ACETAMINOPHEN (123) TACROLIMUS (104) ADALIMUMAB (99) DOXYCYCLINE (94) CYCLOSPORINE (91) MYCOPHENOLATE MOFETIL (80)

Which CEFOTAXIME Alternatives Have Lower Intracranial pressure increased Risk?

CEFOTAXIME vs CEFOXITIN CEFOTAXIME vs CEFPODOXIME CEFOTAXIME vs CEFPODOXIME PROXETIL CEFOTAXIME vs CEFPROZIL CEFOTAXIME vs CEFTAROLINE

Related Pages

CEFOTAXIME Full Profile All Intracranial pressure increased Reports All Drugs Causing Intracranial pressure increased CEFOTAXIME Demographics